Exhibit 991 · Congressional testimony
Opening statement of Hon. Bart Stupak, “Direct-to-Consumer Advertising: Marketing, Education, or Deception?” (Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce)
Nearly ten years ago, the U.S. Food and Drug Administration (FDA) relaxed its rules related to direct-to-consumer (DTC) advertisements for prescription pharmaceutical products.
Chairman’s statement opening the hearing on three TV ad campaigns (Lipitor with Robert Jarvik, Vytorin “Food and Family,” Procrit). Gives the chairman’s figures for DTC spending ($1.1 billion in 1997, $4.2 billion in 2005) and states that Merck and Schering-Plough’s Vytorin ads resulted in $5 billion in sales in 2007. A member’s statement, not a finding.
- Source
- U.S. House of Representatives
- Date
- 8 May 2008
- Quoted from
- Statement, p. 1
- Grade
- Primary record
- Document
- https://webarchive.library.unt.edu/eot2008/20090102234502if_/http://energycommerce.house.gov/Subcommittees/OI-Stupak/050808.OI.hrg.DTC.pdf
- Accessed
- 2026-11-10
- Cited by
- Findings citing this exhibit
- Note
- Archived copy of the committee’s 2008 page (UNT End of Term web archive). Hearing transcript or GPO hearing record not located.